A new treatment option, Datroway (datopotamab deruxtecan or Dato-DXd), is now available for people with non-small cell lung ...

The new lung cancer screening program needs to be independently evaluated to keep it on track, and to minimise the harms.

Nearly a quarter of all newly-diagnosed patients with advanced lung cancer are not given a test that could improve their chances for long-term survival and reduce their side effects.

During June, investigators reported new data that has advanced the treatment landscape for lung cancer, including new FDA ...

Trained on multi-hospital data, iSeg spots moving tumors doctors sometimes miss, edging radiation treatment toward pinpoint ...

From July, eligible Australians will be screened for lung cancer as part of the nation's first new cancer screening program ...

The approval of sunvozertinib, an oral irreversible EGFR inhibitor, was supported by data from the WU-KONG1B trial (ClinicalTrials.gov Identifier: NCT03974022 ). The primary efficacy population ...

Cancer is not a welcome diagnosis, but breakthroughs in genetic sequencing and immunotherapy are making some cancers easier ...

Researchers at McMaster University, Cleveland Clinic and Case Comprehensive Cancer Center have uncovered how a protein long ...

Researchers at McMaster University, Cleveland Clinic and Case Comprehensive Cancer Center have uncovered how a protein long ...